The present invention provides a pharmaceutical agent or compositioncontaining one or more peptides having theamino acid sequence of SEQ ID NO: 1 or 2, or one or more polynucleotidesencoding such a peptide formulated for the treatmentand/or prevention of cancer in a subject whose HLA-A antigen is HLA-A0206.Furthermore, the present invention provides amethod of inducing CTL and antigen-presenting cells using such peptides,polynucleotides or pharmaceutical agents.